Form 8-K - Current report:
SEC Accession No. 0001299933-17-000263
Filing Date
2017-03-17
Accepted
2017-03-17 16:16:15
Documents
2
Period of Report
2017-03-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_54700.htm 8-K 11445
2 EX-10.1 exhibit1.htm EX-10.1 7966
  Complete submission text file 0001299933-17-000263.txt   20870
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 17698171
SIC: 2834 Pharmaceutical Preparations